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e show here the transient activation of the small
GTPase Rac, followed by a rise in reactive oxygen
species (ROS), as necessary early steps in a signal
transduction cascade that lead to NF
 
 
 
B activation and
collagenase-1 (CL-1)/matrix metalloproteinase-1 production
after integrin-mediated cell shape changes. We show evi-
dence indicating that this constitutes a new mechanism for
ROS production mediated by small GTPases. Activated
RhoA also induced ROS production and up-regulated CL-1
expression. A Rac mutant (L37) that prevents reorganization
of the actin cytoskeleton prevented integrin-induced CL-1
W
 
expression, whereas mutations that abrogate Rac binding
to the neutrophil NADPH membrane oxidase in vitro (H26
and N130) did not. Instead, ROS were produced by integrin-
induced changes in mitochondrial function, which were
inhibited by Bcl-2 and involved transient membrane potential
loss. The cells showing this transient decrease in mito-
chondrial membrane potential were already committed
to CL-1 expression. These results unveil a new molecular
mechanism of signal transduction triggered by integrin
engagement where a global mitochondrial metabolic re-
sponse leads to gene expression rather than apoptosis.
 
Introduction
 
Reactive oxygen species (ROS)* are intermediaries in signal
transduction cascades regulating cell proliferation, differentia-
tion, and death (for reviews see Thannickal and Fanburg,
2000; Droge, 2002). A prooxidant state may promote
proliferation (Huang et al., 2000), and the expression of an
exogenous oxidase induces cell transformation (Suh et al.,
1999), whereas diminution of intracellular ROS levels by
overexpression of manganese superoxide dismutase inhibits
proliferation (Li et al., 1998). ROS are also involved in
cell differentiation. During PC12 differentiation, NGF-
induced ROS production is required for neurite outgrowth
(Suzukawa et al., 2000). The intracellular redox status influ-
ences the balance of self-renewal and differentiation of glial
precursor cells (Smith et al., 2000). ROS are also induced
during cell stress, cell death, and senescence (Lee et al., 1999).
The participation of ROS in such diverse cellular processes
suggests a tight control for their production and function.
In most of these pathways, the mechanisms for ROS
production and their molecular targets remain largely un-
known. At least three distinct mechanisms have been
identified: upon neutrophil activation, superoxide is produced
in the phagosome by a membrane oxidase to kill the endocy-
tosed pathogen. In nonphagocytic cells, a different mechanism
is used in association with activation of EGF (Bae et al., 1997)
and PDGF receptors (Sundaresan et al., 1995). In these
systems, ROS are produced by a distinct oxidase at the plasma
membrane, inhibiting phosphatases and potentiating tyrosine
kinases signaling (Lee et al., 1998; Barrett et al., 1999).
Mitochondria are the third and most important source
for ROS in every cell type, where 1–5% of the transported
electrons is diverted to the formation of superoxide instead
of water (Boveris et al., 1972). Although the molecular
mechanisms involved in the mitochondrial switch to ROS
production are not well understood, multiple pathways
may converge to modify mitochondrial function. More-
over, recent studies also indicate that the production of
ROS may be accompanied by changes in mitochondrial
metabolism (Nemoto et al., 2000; Nicholls and Budd,
2000). The rate of mitochondrial superoxide production is
modulated during TNF
 
 
 
 signaling (Schulze-Osthoff et al.,
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1993; Sanchez-Alcazar et al., 2000), hypoxia (Vanden
Hoek et al., 1997; Chandel et al., 1998), and apoptosis
(Cai and Jones, 1998).
The small GTPase Rac has emerged as a common media-
tor of ROS production in diverse signaling pathways that
lead to mitogenesis, gene expression, and stress responses
(Irani et al., 1997; Page et al., 1999; Ozaki et al., 2000; Su-
zukawa et al., 2000). The molecular mechanisms involved
have been identified through the use of mutations in Rac
that modify its interaction with effector proteins. The best
understood mechanism is promotion of ROS production in
neutrophils where Rac2 binds to a NAD(P)H oxidase
through the insertion domain and residue 26 in the effector
domain to mediate assembly and function of the burst oxi-
dase at the plasma membrane (Freeman et al., 1996). In
most other cell types, the oxidase remains unidentified. In
Ras-induced NIH 3T3 cell transformation, Rac1 is neces-
sary and sufficient to induce ROS production by a mecha-
nism dependent on the insertion domain (residues 124–
135) (Irani et al., 1997; Joneson and Bar-Sagi, 1998).
However, there are other pathways where Rac promotes
ROS production by a distinct mechanism. During PDGF-
induced cyclin D expression, Rac-mediated ROS production
depends on the residues 33 and 37 of the effector domain
(Joyce et al., 1999; Page et al., 1999). Rac mediates ROS
production during noncytotoxic TNF
 
 
 
 signaling by an in-
direct mechanism involving phospholipase A2 (Woo et al.,
2000). These observations suggest that Rac may act at differ-
ent steps to control ROS production.
In rabbit synovial fibroblasts (RSFs), clustering of inte-
grins by anti-
 
 
 
5 integrin antibodies leads to altered adhesion
followed by the reorganization of the actin cytoskeleton and
the production of ROS. As a result, the transcription factor
NF
 
 
 
B is activated, inducing the expression of IL-1 and ma-
trix metalloproteinase (MMP)-1/collagenase-1 (CL-1) (Khe-
radmand et al., 1998). In the present study, we have eluci-
dated the pathway by which integrin-mediated signaling
induces ROS production.
 
Results
 
Integrin ligation activates Rac upstream from ROS and 
CL-1 induction
 
We have observed previously that integrin-dependent cell shape
changes in RSFs induce CL-1 gene expression through a Rac-
and ROS-dependent mechanism (Kheradmand et al., 1998).
The antioxidants Tiron (1,2-dihidroxybenzene-3,5-disulphonic
acid; a superoxide scavenger) or catalase prevented CL-1 in-
duced by anti-
 
 
 
5 monoclonal antibody (mAb; a fibronectin re-
ceptor function-perturbing antibody BIIG2) (Fig. 1 A). To
measure whether soluble anti-
 
 
 
5 mAb increases endogenous
ROS production, we used H
 
2
 
O
 
2
 
-driven peroxidase oxidation of
homovanillic acid into a fluorogenic product. This assay allows
the analysis of ROS production in the extracellular medium
without compromising cell integrity or shape. Intracellular su-
peroxide ions are rapidly transformed by superoxide dismutases
into H
 
2
 
O
 
2
 
, a more stable and membrane-permeable species,
which diffuses in the cytosol and to the extracellular fluid.
Upon addition of anti-
 
 
 
5 mAb, we detected a transient increase
in H
 
2
 
O
 
2
 
, which peaked at 120 min (Fig. 1 B).
Our previous experiments with overexpression of GTP-
ase function-altering mutants suggested a role for Rac in
anti-
 
 
 
5 mAb–induced H
 
2
 
O
 
2
 
 and CL-1 production. To
demonstrate whether endogenous Rac is activated during
integrin-induced cell shape change, we prepared cell lysates
from cultures treated with anti-
 
 
 
5 mAb for different inter-
vals. Activated Rac was isolated from the cell lysates using
the recombinant Rac-binding domain of PAK bound to
agarose beads (Benard et al., 1999) and detected with anti-
Rac antibodies by Western blot analysis of the precipitates.
As a control, GTP or GDP was directly added to lysates.
After integrin activation, Rac–GTP levels increased tran-
siently peaking between 30 and 60 min (Fig. 1 C). Densi-
tometric analysis evidenced a 2.8-old increase in the levels
of Rac activity, which returned to basal levels after 60 min.
Careful comparison of the kinetics of Rac activation with
the timing of ROS production
 
,
 
 showed that Rac activation
(Fig. 1 C) precedes the rise in ROS production (Fig. 1 B),
which peaks 2 h after addition of anti-
 
 
 
5 mAb. Rac is nec-
essary for the integrin-dependent increase in H
 
2
 
O
 
2
 
 produc-
tion because a dominant interfering Rac mutant (RacN17)
prevented the rise in H
 
2
 
O
 
2
 
 (unpublished data) as we found
previously (Kheradmand et al., 1998). Moreover, activated
Rac is sufficient for H
 
2
 
O
 
2
 
 production because expression
of an activated mutant, RacV12, induced both a rise in
H
 
2
 
O
 
2
 
 and the downstream induction of CL-1 (Fig. 1 D).
Other members of the Rho GTPase family also mediate in-
tegrin-dependent signaling (Werner et al., 2001) and cyto-
skeletal reorganization (Nobes and Hall, 1995; Caron and
Hall, 1998). We found that activation of Rac was not
unique in its ability to induce a H
 
2
 
O
 
2
 
 rise and CL-1 ex-
pression. Constitutively activated Rho (RhoA V14) (Fig. 1
D) but not constitutively activated Cdc42 V12 (unpub-
lished data) was also effective in inducing H
 
2
 
O
 
2
 
 and CL-1
production. This experiment shows that ROS induction is
not restricted as a downstream consequence of Rac activa-
tion but is triggered by RhoA.
To gain insights into the mechanism used by GTPases to
trigger an increase in ROS production and induce CL-1 ex-
pression, we used point mutations that selectively disrupt ef-
fector domain functions of the constitutively active mutants
RacV12 and RacL61 (Westwick et al., 1997). When we
cotransfected RSFs with a panel of different Rac effector do-
main point mutants together with a CL-1 promoter reporter
construct, we observed that only the mutant L37 was com-
pletely unable to induce expression of a CL-1 (Fig. 2 A) or
NF
 
 
 
B (Fig. 2 B) promoter–reporter constructs. We com-
pared the RacV12 H26 mutant in the switch 1 effector do-
main with the RacV12 N130 mutant in the insertion do-
main, both of which can activate other Rac effectors, such as
PAK, but cannot activate the neutrophil oxidase in vitro
(Freeman et al., 1996). In contrast to the L37 mutant, nei-
ther mutant was impaired in the induction of the expression
of the NF
 
 
 
B promoter, a step in the pathway more proximal
to the integrin signal than CL-1 expression (Fig. 2 B), or of
the CL-1 promoter (unpublished data). These results sug-
gest that Rac activates a signaling pathway by an effector
molecule that requires binding through residue 37 to induce
NF
 
 
 
B activation and CL-1 expression, thus pointing to a
novel mechanism for induction of ROS. 
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While mutants in residue 37 disrupt several Rac-depen-
dent cytoskeletal events, they do not abolish JNK or PAK ac-
tivation (Nobes and Hall, 1995; Joneson et al., 1996;
Westwick et al., 1997). We found that although the RacV12
L37 mutant abrogated Rac-induced reorganization of the ac-
tin cytoskeleton (Fig. 2 C), it still activated JNK (Fig. 2 D) as
it has been described before (Joneson et al., 1996; Lamarche
et al., 1996). RSFs transfected with the L37 mutant main-
tained a fibroblast-like morphology and extensive stress fibers
without visible lamellipodia formation and actin reorganiza-
tion. In contrast, RacV12-transfected cells changed shape,
adopting a dish-like round morphology with abundant
lamellipodia at the cellular edges and actin filaments orga-
nized into a subcortical array rather than into stress fibers.
The H26 and N130 mutants showed a RacV12-like pheno-
type. Together with the observation that activated RhoA can
also induce ROS and CL-1 production, these results further
support our conclusion that Rac-mediated ROS production
is by a mechanism different from the activation of a mem-
brane oxidase. In keeping with these observations, the fla-
voprotein inhibitor diphenylene iodonium did not inhibit
integrin-induced CL-1 expression (unpublished data).
 
Mitochondria are the source of integrin-mediated 
ROS production
 
An important source of ROS is the nonenzymatic genera-
tion of superoxide as a by-product of mitochondrial metabo-
lism. In our assay, the H
 
2
 
O
 
2
 
 signal was inhibited when the
cells were preincubated with a superoxide scavenger, Tiron,
and abolished by the simultaneous addition of catalase to the
reaction mixture (Fig. 3 A), corroborating that the detected
signal is effectively H
 
2
 
O
 
2
 
 and suggesting that the H
 
2
 
O
 
2
 
 is
Figure 1. Anti- 5 mAb induces H2O2 production and Rac activation. (A) Anti- 5 mAb induces CL-1 expression by an oxidant-dependent 
mechanism. Cells were incubated in the absence or presence of 1 mM Triton or 200 U/ml catalase with 10  g/ml anti- 5 1 mAb. After 
24 h, CL-1 production was measured by slot blot analysis of the supernatants. This is one of three experiments. (B) Anti- 5 mAb induces a 
transient increase in H2O2 production. Cells were incubated for different intervals without or with anti- 5 1 mAb, and H2O2 production 
was measured. One of twelve experiments is represented. (C) Anti- 5 mAb induces transient activation of endogenous Rac. Cells were 
incubated for different intervals without or with 10  g/ml anti- 5 mAb. An aliquot (1/10) of the lysate was separated to measure total Rac, 
and the rest was incubated with the Rac-binding domain of PAK-agarose to isolate activated Rac. The amount of precipitated Rac was 
determined by Western blotting. One of two experiments is represented. (D) Constitutively activated Rac and RhoA induce H2O2 production 
and CL-1 induction. RSFs were transiently transfected with RacV12, RhoV14, or empty vector (vector) and the CL-1 promoter–luciferase 
construct. After 48 h of transfection, H2O2 production in the absence and presence of 20 U/ml of catalase was measured, and luciferase 
activity was determined in cell lysates. 
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originated by superoxide. The H
 
2
 
O
 
2
 
 signal induced by anti-
 
 
 
5 mAb was abrogated by inhibition of the function of mi-
tochondrial respiratory chain complex 1 by 1 
 
 
 
M rotenone,
complex 3 by 25 
 
 
 
M antimycin A, or complex 4 by 500
 
 
 
M KCN (Fig. 3 A). These results suggest that the mito-
chondrial respiratory chain is responsible for the rise in ROS
induced by anti-
 
 
 
5 mAb.
Tetrazolium salts are reduced to formazan by superoxide
in vitro (Flohe and Otting, 1984) and by dehydrogenases
and reductases in tissues. Therefore, they have been used as
an indicator of mitochondrial metabolism and for succinate
dehydrogenase (Powers et al., 1993). As an alternative strat-
egy to evaluate mitochondrial metabolic/redox function, we
incubated RSFs with nitroblue tetrazolium (NBT), which
generates an insoluble formazan upon reduction. Anti-
 
 
 
5
mAb induced an increase in NBT precipitate associated with
an intracellular membranous compartment (Fig. 3 B). The
observed staining was dependent on mitochondrial func-
tion, since it was inhibited by rotenone, and was dependent
on reduction, since it was inhibited by 10 mM 
 
N
 
-acetyl-
 
L
 
-cysteine. Furthermore, we analyzed whether RacV12 expres-
sion promotes NBT precipitation. To do this experiment,
RacV12 was cotransfected with histone 2B–GFP to mark
the transfected cells. When used in a 2:1 ratio, 75% of the
cells expressing GFP coexpressed RacV12 evidenced by
immunofluorescence (unpublished data). In these cells,
RacV12 induced NBT precipitation associated with an in-
tracellular membranous compartment of similar distribution
to that induced by anti-
 
 
 
5 mAb (Fig. 3 C). Quantification
of the NBT precipitate by solubilization showed a signifi-
cant (
 
P 
 
  
 
0.05) increase in NBT precipitation induced by
RacV12 but not by RacV12L37 or RacN17 (Fig. 3 D).
Considering that only a subset of RSFs express the Rac mu-
tants in these transiently transfected cultures, these data in-
dicate a strong influence of activated Rac in mitochondrial
metabolic/redox function. Together, these results suggest
that integrins modify mitochondrial function to produce
ROS by a novel Rac-dependent mechanism.
Because the diversion of electrons to form superoxide can
lead to a dissipation of membrane potential (
 
  
 
) (Zoratti
and Szabo, 1995; Madesh and Hajnoczky, 2001), we exam-
ined whether integrin cross-linking induces changes in mito-
chondrial membrane potential. We analyzed the distribu-
tion of the dual emission potentiometric probe JC-1. When
high negative potential drives the dye concentration above a
threshold, the green fluorescent monomers (low membrane
potential) form red fluorescent aggregates (high membrane
 
Figure 2.
 
Activated
 
 
 
Rac induces ROS production through a novel 
mechanism
 
. (A) Effect of point mutations in the effector domain of 
RacV12 on signal transduction. A series of effector domain point 
mutants on RacV12 or RacL61 backbones were cotransfected with a 
CL-1 promoter–luciferase construct into RSFs, and luciferase activity 
was measured 72 h later. The bottom panel shows the expression of 
the myc-tagged Rac constructs in 2 
 
 
 
 10
 
4
 
 cells. This experiment is 
representative of four. (B) Effect of RacV12RacV12L37 and RacV12 
mutants that are unable to interact with the neutrophil oxidase in 
vitro on NF
 
 
 
B activation. RSFs were transiently cotransfected with 
RacV12 or RacV12 containing the point mutations L37, H26, or N130 
plus a NF
 
 
 
B promoter–luciferase construct, and luciferase activity 
was measured 72 h later. The bottom panel shows the expression of 
the myc-tagged Rac constructs in 2 
 
 
 
 10
 
4
 
 cells. This experiment is 
representative of four. (C) Effect of RacV12 point mutants on the 
actin cytoskeleton organization. Fluorescence microscopy of cells 
transfected with Myc-tagged Rac mutants and immunostained for 
the Myc tag (green) and for actin (red). Bar, 50 
 
 
 
m. (D) Effect of 
RacV12 and the L37 mutant on JNK kinase activation. Cos 7 cells 
were transiently transfected with empty vector (control), RacV12, or 
RacV12L37. After 24 h in the absence of serum, endogenous JNK 
was immunoprecipitated, and kinase activity was measured using 
GST–c-jun as a substrate and revealed by autoradiography. 
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were highly polarized again (Fig. 4 A, e), and no cells with
only green mitochondria were detected, indicating that this
is a reversible change. Cytochalasin D, which also induces
ROS production (Kheradmand et al., 1998), induced mito-
chondrial depolarization after 2 h of treatment (Fig. 4 A, b).
These results further support the biochemical evidence for
cell shape–dependent control of mitochondrial function.
But are the observed changes in mitochondrial potential
linked to the signal transduction cascade triggered by anti-
 
 
 
5
mAb? We analyzed whether the cells with depolarized mito-
chondria after anti-
 
 
 
5 mAb treatment are the same ones that
are induced to express CL-1. We treated RSFs with anti-
 
 
 
5
mAb for 4 h and stained them with JC-1 for 15 min at 37
 
 
 
C.
We then separated two populations of cells according to their
Figure 3. Mitochondrial H2O2 production in response to anti- 5 
mAb. (A) H2O2 induced by anti- 5 mAb was competed by the 
addition of 200 U/ml catalase to the reaction mixture or inhibited 
by 1 h pretreatment with 5 mM Tiron or simultaneous addition 
of the respiratory chain inhibitors 1  M rotenone, 25  M antimycin 
A, or 500  M KCN with 10  g/ml anti- 5 mAb. The results 
represent one of three experiments. (B) Anti- 5 mAb induces NBT 
reduction. Bright field microphotographs of NBT-stained cells in 
the absence (control) or presence of 10  g/ml anti- 5 mAb treated 
without or with 1  M rotenone and 10  M N-acetyl-L-cysteine. 
Bar, 50  m. The images are representative of three independent 
experiments. (C) NBT reduction induced by RacV12 expression. 
RSFs were transiently transfected with histone 2B–GFP in the 
absence (control) or presence of RacV12. After 24 h, they were 
stained for 1 h with NBT and fixed. (D) Effect of RacV12L37 on 
RacV12-induced NBT precipitate. RSFs transiently expressing 
RacV12, RacV12L37, or RacN17 were incubated for 1 h with 0.3 
mg/ml of NBT. Reduced NBT was quantified as described in 
Materials and methods (one of two experiments is shown).
 
potential). After 15 min of dye loading at 37
 
 
 
C, most of the
mitochondria in control RSFs were bright orange (Fig. 4 A,
a), indicative of highly energized mitochondria. When the
membrane potential was dissipated with the protonophore
FCCP, all of the mitochondria stained green (Fig. 4 A, f),
corroborating that JC-1 accumulation is driven by mem-
brane potential. After 2 h of anti-
 
 
 
5 mAb treatment, a pop-
ulation of cells had only green-stained mitochondria (Fig. 4
A, c). Frequently, the green staining mitochondria were
present in cells that had rounded in response to the anti-
 
 
 
5
mAb treatment. The number of cells with green-stained mi-
tochondria increased with time from 7 
 
 
 
 1% (SEM) at 0 h
to 21 
 
  4% after 2 h and to 43% after 8 h of anti- 5 mAb
addition. However, by 24 h the mitochondria in all cells362 The Journal of Cell Biology | Volume 158, Number 2, 2002
mitochondrial staining using fluorescence-activated cell sort-
ing, gating to isolate cells with depolarized (green) mitochon-
dria from polarized (orange) mitochondria (Fig. 4 B). Equal
numbers of cells with depolarized mitochondria (green) or
with polarized mitochondria (orange) were plated on glass cov-
erslips and analyzed for CL-1 expression 24 h later. We found
that background and anti- 5 mAb–induced CL-1 expression
segregated with the cells that had depolarized mitochondria
24 h earlier (Fig. 4 C). Although very few cells with depolarized
mitochondria were obtained from control cultures, those cells
did make low levels of CL-1 seen as basal levels, whereas the
cells with polarized mitochondria did not. These results dem-
onstrate that the cells showing mitochondrial membrane depo-
larization are committed to CL-1 expression.
Bcl-2 blocks integrin-mediated signaling for 
CL-1 expression
Cell rounding and detachment can induce apoptosis in some
cell types (Ruoslahti and Reed, 1994). During the induction of
apoptosis, mitochondria are engaged to produce ROS and un-
dergo membrane depolarization, membrane permeability tran-
sition (MPT), release of specific proteins from the intermem-
brane space (cytochrome C, procaspases 2 and 9, Apaf-1, and
AIF), and caspase activation through a mechanism that is not
clear (Kroemer and Reed, 2000). Members of the Bcl-2 family
can inhibit ROS production (Hockenbery et al., 1993; Kane et
al., 1993), membrane potential loss (Gottlieb et al., 2000),
MPT (Marzo et al., 1998), cytochrome C release (Yang et al.,
1997), and caspase activation (Strasser et al., 2000). We hy-
pothesized that in response to triggering integrin-mediated sig-
naling in RSFs the mitochondrial signal transduction is en-
gaged by a mechanism common to apoptosis, yet is resolved
into induction of gene expression instead of cell death.
Neither control cells nor cells treated for 4 h with anti- 5
mAb showed cytochrome C release from mitochondria to
the cytosol by Western blot analysis (Fig. 5 A) or by immuno-
fluorescence (unpublished data). The addition of selective
inhibitors of caspases 1 or 3 or the general caspase inhibitor
Z-VAD fluoromethyl ketone did not inhibit anti- 5 mAb–
induced CL-1 production (Fig. 5 B), although they effec-
tively inhibited staurosporine-induced apoptosis (unpub-
lished data). Anti- 5 mAb induced equivalent amounts of
Figure 4. Mitochondrial depolarization 
and CL-1 induction. (A) Fluorescence 
microscopy of RSFs stained with JC-1. 
Fibroblasts treated without (a), or with 
10  M FCCP (f) for 2 h (c), or 24 h (e) 
with 10  g/ml anti- 5 mAb, 2  g/ml 
cytochalasin D for 2 h (b) or 1  M 
rotenone for 2 h (d) were stained with 
JC-1. Bar, 25  m. High potential 
mitochondria (  140 mV) stain red; 
low potential ( 100 mV) mitochondria 
stain green. Bar, 50  m. (B) Dot plot 
graph of FACS
® analysis of RSFs treated 
for 4 h with anti- 5 mAb and stained 
with JC-1 for 15 min at 37 C. The cells 
with only green fluorescence (R3) and 
the cells with highest red emission (R2) 
were sorted from control and anti- 5 
mAb–treated populations, and equal 
numbers were plated for 24 h on 
fibronectin. (C) CL-1 protein produced 
by each population of cells was measured 
by slot blot. Integrins activate mitochondrial signaling | Werner and Werb 363
Figure 5. The changes in mitochondrial function in response to 
cell shape change induced by anti- 5 mAb differ from apoptosis. 
(A) Western blot for cytochrome C in 50  g of supernatant (SN) or 
100  g high speed membrane fraction (P) prepared from cells untreated or treated for 4 h with 10  g/ml anti- 5 mAb. (B) Effect of caspase inhibitors 
on anti- 5 mAb–induced CL-1 expression. RSFs were incubated for 30 min with 200  M Z-VAD–FMK, caspase 1 inhibitor VI, caspase 4 inhibitor II, 
or DMSO followed by addition of anti- 5 mAb. After 24 h, CL-1 in the supernatant was measured by slot blot. (C) Effect of cyclosporin A on CL-1 
expression induced by anti- 5 mAb. RSFs were incubated for 30 min with 20  M cyclosporin A or DMSO followed by addition of anti- 5 mAb. 
After 24 h, CL-1 in the supernatant was measured by slot blot. (D) Human Bcl-2 inhibits RacV12-induced NF B activation, CL-1 expression, and 
NBT precipitation. RSFs were cotransfected with empty vector or RacV12 or hBcl-2, and constructs for  -galactosidase, NF B, or CL-1 promoters 
coupled to luciferase. After 48 h of transfection, luciferase and  -galactosidase activity were measured in the cell lysates. The results are corrected by 
transfection efficiency using  -galactosidase activity as reference. This experiment represents one of three. (E) Effect of anti- 5 mAb on cell viability: 
growth curve upon serum restitution after anti- 5 mAb treatment. Cells were treated for 24 h without or with 10  g/ml of anti- 5 mAb in serum-free 
medium (0.2% LH). RSFs were replated and grown in 10% FBS. After different intervals, MTT incorporation was measured. Each point represents 
the average of triplicates with the error bars too small to appear represented. (F and G) Fluorescence microscopy of RSFs expressing CL-1. Immuno-
staining for CL-1 (green) and costaining with DAPI (blue) in cells incubated (F) without or (G) with 10  g/ml of anti- 5 mAb for 24 h. Bar, 100  m.364 The Journal of Cell Biology | Volume 158, Number 2, 2002
CL-1 in control cells or cells treated with an inhibitor of
MPT, cyclosporin A (Fig. 5 C). In contrast, we found that
Bcl-2, which blocks several mitochondrial-dependent pro-
cesses during apoptosis, inhibited integrin ligation-induced
signal transduction. The transient overexpression of human
Bcl-2 in RSFs inhibited RacV12-induced NBT precipitation
as a measure of mitochondrial metabolic/redox function and
transcriptional activation of both NF B and CL-1 promot-
ers (Fig. 5 D). Importantly, the anti- 5 mAb treatment did
not induce apoptosis at 24 h cells cultured without serum as
analyzed by the TUNEL method (unpublished data) or
by growth rates upon serum restitution as measured by di-
methylthiazolyldiphenyltetrazolium bromide (MTT) metabo-
lism (Fig. 5 E). After 24 h of anti- 5 mAb treatment, all of
the cells expressing CL-1 exhibited a normal nuclear mor-
phology by DAPI staining, confirming that CL-1 induction
is not associated with cell death (Fig. 5, F and G). Together,
these results further support a role for mitochondria in inte-
grin-dependent signal transduction by a mechanism that can
be regulated by Bcl-2 but that is different from apoptosis.
Discussion
We have shown here that integrins activate Rho GTPase
function to produce ROS for signal transduction production
by a novel mechanism different from the activation of a
plasma membrane NADPH oxidase. Downstream of Rac,
the pathway engages mitochondria as a signaling center for
processes distinct from apoptosis.
Integrin control of mitochondrial function
Four independent lines of evidence advocate a role for mito-
chondria in integrin-induced signal transduction. The first
line of evidence for mitochondrial involvement in signal
transduction is anti- 5 mAb–induced mitochondrial depo-
larization in cells committed to CL-1 gene expression.
Second, we found that integrin cross-linking induces a
ROS increase that requires the function of complexes 1, 3, or
4 of the respiratory chain. Glycolysis maintains the levels of
ATP upon inhibition of the respiratory chain in primary fi-
broblasts (McKay et al., 1983). Thus inhibition of respiration
does not hinder the mitochondrial pathway by causing ATP
depletion. In confirmation, blocking mitochondrial respira-
tion with rotenone alone was not sufficient to cause mito-
chondrial depolarization due to reverse activity of the ATP
synthase. In isolated mitochondria, complexes 1 and 3 partic-
ipate directly in ROS production. NADPH or succinate in-
duces superoxide production under conditions of slow respi-
ration (state 4, not conductive to ATP synthesis) where the
reduced state of the ubisemiquinone favors the direct transfer
of electrons to oxygen (Turrens et al., 1985). Antimycin A en-
hances but rotenone and cyanide inhibit this mechanism. Al-
though integrin-induced ROS production was sensitive to ro-
tenone and cyanide, we could not detect enhanced ROS
production induced by antimycin A. This deviation can be
explained by differences in the mitochondrial metabolic state
or in antimycin A sensitivity of intact cells. Alternatively, the
site for superoxide production could be at cytochrome B or
downstream of the antimycin A block. Such a mechanism has
been invoked for ROS production induced by release of cyto-
chrome C to the cytosol during apoptosis (Cai and Jones,
1998; Sanchez-Alcazar et al., 2000). However, this mecha-
nism seems unlikely because we did not detect cytochrome C
release, indicating the existence of a different mechanism.
The third line of evidence for mitochondrial participation
in integrin-mediated signal transduction comes from the in-
crease in anti- 5 mAb–induced NBT reduction into insolu-
ble formazan. Even though tetrazolium salts can be reduced
by several dehydrogenases, the results are consistent with
NBT reduction in mitochondria. We found that NBT re-
duction occurs at the same time of the detected rise in H2O2
production (unpublished data) and distributes into an intra-
cellular and vesicular compartment. RacV12, which induced
H2O2 production and signal transduction, was sufficient to
induce a similar staining pattern. Additionally, formazan
deposition was abolished by interfering with mitochondrial
function using rotenone and inhibited by the effector do-
main mutant L37 or by Bcl-2 when induced by RacV12.
A fourth line of evidence constitutes Bcl-2 inhibition of
RacV12 signaling. Although Bcl-2 localizes to mitochondria,
nucleus, and ER, its inhibition of NBT reduction manifests a
role in the control of mitochondrial homeostasis. Accordingly
with this view, accumulating evidence indicates that rather
than antagonizing specific steps of apoptosis Bcl-2 regulates
mitochondrial metabolism, including ADP/ATP exchange
(Vander Heiden et al., 1999), permeability to metabolic an-
ions (Vander Heiden et al., 2000), and preventing membrane
potential dissipation by increasing proton efflux (Shimizu et
al., 1998). These mechanisms predict the participation of Bcl-2
in nonapoptotic processes. Interestingly, overexpression of
Bcl-xL in pancreatic islet   cells inhibits not only apoptosis
but also mitochondrial response to glucose (Zhou et al.,
2000). Thus, the simplest interpretation for our results is that
Bcl2 interferes with signal transduction by counteracting Rac-
induced changes in mitochondrial metabolism.
Rac mediates ROS production through a 
novel mechanism
We show that integrins engage mitochondria through the
activation of Rac, which constitutes a novel mechanism for
this GTPase to mediate ROS production. We have shown
previously that integrin ligation induces ROS production by
a Rac-dependent mechanism (Kheradmand et al., 1998).
Now we show that this GTPase is activated downstream of
integrin cross-linking before ROS levels increase at 2 h.
These nonoverlapping kinetics suggest a novel indirect
mechanism for Rac-dependent ROS induction, involving
one or more intermediate steps after the GTPase activation.
This mechanism is further supported by our observation
that RhoA, although unable to activate the neutrophil oxi-
dase (Abo et al., 1991), also induces H2O2 and CL-1 pro-
duction in RSFs. This is not as a result of cross-talk between
the GTPases because integrin-mediated signaling is selec-
tively inhibited by interfering with the function of one of
the GTPases, i.e., only RacN17 inhibits anti- 5 mAb sig-
naling (Kheradmand et al., 1998) and only RhoA N19 in-
terferes with integrin-mediated phagocytosis signaling (Wer-
ner et al., 2001). Our findings with the effector domain
mutants of Rac further support an indirect mechanism dis-
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Our results indicate that Rho GTPases modulate mito-
chondrial function through an indirect mechanism, which
could involve the control of the anti/proapoptotic function
of the Bcl-2 family members and/or the organization of the
cytoskeleton. Integrins can engage multiple mechanisms
that could sustain cell survival by controlling the function of
different members of the Bcl-2 family. Phosphatidylinositol
3-kinase, which can be activated by Rac (Bokoch et al.,
1996), activates PKB/Akt kinase and modulates the apop-
totic function of Bad (del Peso et al., 1997). However, in
our system inhibitors of phosphatidylinositol 3-kinase did
not affect anti- 5 mAb–induced signaling (unpublished
data), suggesting that signaling proceeds by a different
mechanism. Integrins can also restrict Bax localization dur-
ing epithelial cell adhesion to extracellular matrix (Gilmore
et al., 2000). An additional mechanism implied in the litera-
ture, but not yet demonstrated, is the control of the function
or localization of members of the Bcl-2 family by integrins
through interaction with members of the 14-3-3 scaffolding
protein family. These proteins have multiple interaction
partners including  1 integrins during cell spreading (Han
et al., 2001) and p190RhoGEF (Zhai et al., 2001). On the
other end of the cascade, the interaction of 14-3-3 with Bad
prevents its proapoptotic function (Datta et al., 2000).
Alternatively, this indirect mechanism could involve
the actin cytoskeleton. Rac induction of ROS production
through a signal conveyed by reorganization of the actin cy-
toskeleton is consistent with the ability of cytochalasin D
(Kheradmand et al., 1998) and activated RhoA to induce
H2O2 and CL-1 production. A tantalizing candidate to cou-
ple mitochondrial function to actin cytoskeleton reorganiza-
tion is gelsolin, a member of a multigene family of proteins
with actin filament severing and capping activity. In prelimi-
nary studies, we have found that microinjection of gelsolin
protein into RSFs induces shape change, motility, and ex-
pression of CL-1 (unpublished data). Gelsolin is a down-
stream target of Rac in fibroblasts (Azuma et al., 1998) and
neutrophils (Arcaro, 1998). Gelsolin inhibits caspase activa-
tion (Azuma et al., 2000) and modifies mitochondrial mem-
brane potential by modulating VDAC activity (Kusano et al.,
2000), thus inhibiting apoptosis (Koya et al., 2000). Gelsolin
may also be involved in signal transduction, since null fibro-
blasts have a blunted proinflammatory response (Witke et al.,
1995). Interestingly, in RSFs, integrin-mediated activation of
Rho and Rac and ROS production induces the expression of
proinflammatory cytokines through activation of NF B
(Kheradmand et al., 1998; Werner et al., 2001).
Together, we favor a model for the participation of mito-
chondria in integrin signaling in a nonapoptotic cascade that
leads to gene expression and cell differentiation.
Inhibition of integrin (this paper) and RacV12 (Kherad-
mand et al., 1998) signaling by antioxidants indicates that
mitochondria are engaged to generate superoxide as an inter-
mediary in the signal transduction pathway. We also found
that in cells committed to signaling mitochondria undergo
membrane depolarization. Our results are insufficient to
demonstrate a direct relationship between both mitochon-
drial changes. However, the time course of both events (at
the time we observe a sharp decrease in H2O2 production,
we still detect an increase in the number of cells with depo-
larized mitochondria) indicates that superoxide is produced
first, and then membrane potential is lowered. This order of
events would be consistent with the known mitochondrial
superoxide production dependency from membrane poten-
tial (Korshunov et al., 1997) and the regulation of VDAC
function by superoxide (Zoratti and Szabo, 1995; Madesh
and Hajnoczky, 2001). Further experiments are needed to
demonstrate the soundness of this model.
Few other examples exist showing that mitochondria partic-
ipate in signal transduction by capturing Ca
 2 or producing
ROS (for review see Duchen, 1999). In most cases, ROS pro-
duction and membrane potential loss have been associated
with apoptosis. However, induction of apoptosis and gene ex-
pression appear to share a common pathway of signaling
through mitochondria where the outcome is dictated by sur-
vival signals. It is instructive to compare the integrin-triggered
pathway with TNF -induced signal transduction. TNF -
induced apoptosis has been studied mainly in cells treated
with cycloheximide or actinomycin D where the absence of
survival pathways provided by the activation of gene expres-
sion shifts the outcome of signaling to cell death. However,
in most normal cell types TNF  induces gene expression
through the activation of NF B, AP-1, JNK, and MAPKK by
a mechanism dependent on mitochondrial respiratory chain
function (Schulze-Osthoff et al., 1993; Goossens et al., 1995),
a pathway that is abrogated by stable manganese superoxide
dismutase overexpression (Manna et al., 1998). Rac is also
part of these dual pathways. Its activity is necessary both for
TNF -mediated apoptosis (Embade et al., 2000) and gene
expression (Esteve et al., 1998). Apoptosis induced by altered
adhesion and FAK function can be compensated by Rac acti-
vation (Almeida et al., 2000). The participation of Rac and
mitochondria in these pathways with dual outcomes suggests
that an additional signal is required. This interpretation is
consistent with observations that Rho and Rac can mediate
apoptosis in the absence of survival signals from serum (Esteve
et al., 1998; Embade et al., 2000) or mediate cell proliferation
and transformation in the presence of these signals.
By largely unexplored mechanisms, mitochondrial function
must be coupled to other cellular functions to accommodate
changes in metabolism requirements. Mitochondria could be
recruited to respond to new metabolic requirements by con-
trolling ATP levels or lipid metabolism or, as it is in this case,
to promote oxidative signaling. More interestingly, mito-
chondria may coordinate parallel signal transduction path-
ways triggered by the altered cytoarchitecture that takes place
during changes in tissue organization, cell locomotion, in-
flammatory responses, wound healing, or tumor progression.
It is interesting to note that many tumor cells have altered mi-
tochondrial function with increased glycolytic metabolism, a
process known as the Warburg effect (Racker, 1983). Altered
adhesion and activation of Rac and Rho GTPase isoforms are
also features of many tumor cells. Whether these processes are
functionally coupled remains to be determined.
Materials and methods
Reagents
Rac activation assay kit was obtained from Upstate Biological, luciferase
assay kit was from Promega,  -galactosidase assay kit was from Tropix, hu-366 The Journal of Cell Biology | Volume 158, Number 2, 2002
man fibronectin was from Roche, and anti–cytochrome C was from BD
PharMingen. FCCP, rotenone, antimycin A, KCN, MTT, cyclosporin A, cy-
tochalasin D, peroxidase, homovanillic acid, Tiron, NBT, and H2O2 were
obtained from Sigma-Aldrich. JC-1, rhodamine-conjugated phalloidin, and
Alexa-conjugated secondary antibodies were obtained from Molecular
Probes. Catalase, Z-VAD-FMK, Casp1 VI, Casp 4 II, and N-acetylcysteine
were obtained from Calbiochem.
Cells
RSFs were isolated as described previously (Aggeler et al., 1984) and cul-
tured between passages 3 and 10 in DME H-21 supplemented with 10% FBS
(Hyclone) and 2 mM glutamine in 5% CO2 at 37 C. For the experiments,
RSFs from confluent cultures were plated in DME supplemented with 0.2%
lactalbumin hydrolysate (LH) on dishes coated previously for 2 h with 20  g/
ml of human fibronectin in PBS and then blocked for 30 min with 0.2% LH-
DME. After 1 h to allow cell spreading, 10  g/ml of protein G–affinity-puri-
fied anti- 5 mAb (BIIG2, a gift from Dr. C. Damsky, University of California,
San Francisco, CA) was added. As controls, purified rat immunoglobulins or
unrelated antibodies of the same species and isotype were used.
H2O2 assay
Confluent RSFs were plated on fibronectin-coated plates for at least 4 h be-
fore the experiments. Anti- 5 mAb was added at 20-min intervals, and at
the end the cells were washed with PBS and incubated with Hank’s bal-
anced salt solution without phenol red, 1 mM Hepes, 100  M homovanil-
lic acid, and 5 U/ml HRP type VI for 1 h at 37 C (Baggiolini et al., 1986).
The samples were alkalinized with 0.1 M glycine-NaOH, pH 10, and the
formation of the fluorescent product was measured in a Fluorolog 3 Instru-
ments SA fluorimeter at excitation of 321 nm and emission at 421 nm. No
reading was detected when peroxidase or substrate was omitted. Standards
were prepared from a 30% wt/vol H2O2 stock solution. The limit of detec-
tion was 0.05  M, whereas the basal activity detected was 0.1  M. The
amount of H2O2 produced was calculated by adding the three readings
where anti- 5 mAb–induced H2O2 production peaked. The respiratory
chain inhibitors were added at the first time of anti- 5 mAb addition
(2.2 h). After the PBS wash, the residual amount of inhibitors did not inter-
fere with the reading of a standard amount of H2O2 added (unpublished
data). The readings were corrected for cell number.
Rac activation assay
To measure Rac activation, confluent cultures were cultured overnight in
DME-LH. RSFs (5   10
6) were plated on fibronectin-coated plates for 4 h
and then incubated with 10  g/ml of anti- 5 mAb for different periods.
Cells were lysed in 500  l of lysis buffer and 450  l incubated with PAK1-
RBD agarose following the manufacturer recommendations (Upstate Bio-
technology). The total Rac present in the lysate was measured in 50  l be-
fore incubation with PAK1-RBD and activated Rac bound to PAK-RBD
were detected by Western blot.
JNK kinase assay
Transfected Cos 7 cells were lysed in 20 mM Tris, pH 7.6, 250 mM NaCl,
3 mM EDTA, 20 mM   glycerophosphate, 0.5% (vol/vol) NP-40, 1 mM
DTT, 1 mM sodium orthovanadate, and protease inhibitors. JNK was im-
munoprecipitated for 2 h with anti-JNK antibody (Cell Signaling) and
washed two times with kinase buffer. The immune complex-associated ki-
nase activity was measured in kinase buffer (25 mM Hepes, pH 7.5, 20
mM   glycerophosphate, 2 mM DTT, 20 mM MgCl2, 0.1 mM sodium
orthovanadate) incubated with 1  g GST-c-jun and 5  Ci [ -
35S]ATP for
30 min at 30 C. After gel electrophoresis, c-jun phosphorylation was re-
vealed by autoradiography (Sudo and Karin, 2000).
NBT staining
RSFs were incubated for 1 h at 37 C with a filtered solution of 0.3 mg/ml of
NBT in Hank’s balanced salt solution without phenol red during the second
hour of anti- 5 mAb treatment. These conditions were established to optimize
signal over the background differences in staining. The cells were washed
once with PBS and fixed with 0.4% paraformaldehyde for light microscopy.
To quantify NBT precipitation, cells were washed twice with 70% methanol
and fixed for 5 min in 100% methanol. After the wells are allowed to air dry,
the formazan is solubilized with 120  l 2M KOH and 140  l DMSO. The OD
was read in an ELISA plate reader at 590 nm (Rook et al., 1985).
JC-1 staining
RSFs were plated on glass coverslips coated with fibronectin and were
stained with 10  g/ml of JC-1 in 0.2% LH DME for 15 min at 37 C (Smiley
et al., 1991). JC-1 is a hydrophobic carbocyanine compound with delocal-
ized positive charge that allows its cellular distribution driven by negative
potential; when the concentration reaches a threshold, it forms aggregates
with a shift in the absorbed and emitted fluorescence. Therefore, when the
membrane potential is    100 mV the mitochondria appear green, but
under conditions of high membrane potential (   140 mV) high amounts
of JC-1 aggregate and form a red fluorescent complex (Smiley et al., 1991).
Cells were photographed within 5 min under epifluorescence using a
FITC/TR dual band pass filter in a Leica DMR microscope.
For the cell isolation experiments, RSFs were treated for 4 h without or
with 10  g/ml of anti- 5 mAb, stained with JC-1 for 15 min at 37 C, and
then released with trypsin-EDTA. Soybean trypsin inhibitor was added,
and the cells were sorted in a Becton Dickinson FACSVantage SE cell
sorter gated to separate cells by green and orange fluorescence. 5   10
5
cells collected from each condition were plated on fibronectin-coated
glass coverslips and then incubated for an additional 24 h. Secreted CL-1
in the supernatant was measured by slot blot. The number of cells recov-
ered after 24 h was confirmed by counting nuclei after staining with DAPI.
Cytochrome C release
RSFs were incubated for 4 h without or with 10  g/ml of ant- 5 mAb and
homogenized as described (Carthy et al., 1999). Cytochrome C was de-
tected by Western blot analysis of protein in the high speed pellet (100  g
of protein) for mitochondria and supernatant (50  g) for cytosol.
MTT assay
To quantify viable cells, 20  l of 5 mg/ml MTT in PBS was added to 100  l
of culture medium and incubated with RSFs at 37 C for 1 h. Metabolized
MTT was solubilized with 300  l of DMSO, and color development was
measured at 570 nm. Each point shown is the average of triplicates with a
standard deviation too small to be represented in the graph.
Western and slot blot
CL-1 expression was measured by slot blot analysis of serial dilutions of
the treated cell culture supernatants as described previously or by Western
blot analysis of the cell culture supernatants using a mixture of six mono-
clonal anti–rabbit CL-1 mAb (oligoclonal) and an HRP-conjugated anti–
mouse secondary antibody (Tremble et al., 1994). HRP binding was
evidenced by enhanced luminescence reaction, and the bands were quan-
tified by densitometry using Image Quant software for analysis. The refer-
ence value to calculate fold of induction was the basal expression of CL-1
of cells plated on fibronectin without anti- 5 mAb.
Immunofluorescence
The cells were plated on fibronectin-coated glass coverslips. The mono-
layer was washed with PBS and fixed with 4% paraformaldehyde in PBS
for 20 min, permeabilized with 0.1% Triton X-100 for 3 min, and blocked
for 1 h with 15% FBS in PBS. Primary antibodies were diluted in 15% FBS
and incubated for 1 h at 37 C. After three washes with PBS 0.1% Triton
X-100, the samples were incubated with Alexa-labeled secondary antibodies
(Molecular Probes) for 45 min and embedded in Vectashield with DAPI
(Vector Laboratories). Samples were analyzed and photographed using a
Leica DMR microscope.
Plasmids and transfections
Dr. Marc Symons (Picower Institute for Medical Research, Manhasset, NY)
provided the expression plasmids with RhoA V14 (Qiu et al., 1995), and
Dr. Gaston Hayes (Onyx Pharmaceuticals, Richmond, CA) provided the
panel of Rac mutants (Westwick et al., 1997). The NF B reporter plasmid
corresponds to the ELAM promoter from –730 to  52 coupled to lu-
ciferase and was provided by Dr. Ulrike Schindler (Tularik Inc., South San
Francisco, CA) (Schindler and Baichwal, 1994). To measure CL-1 induc-
tion, a minimal CL-1 promoter ( 517 to 63) coupled to luciferase was
used (Kheradmand et al., 1998). In control cells, empty vector or pEGFP1C
(CLONTECH Laboratories, Inc.) was transfected in equal amounts. Dr.
Stanley Korsmeyer (Dana Farber Cancer Institute, Harvard Medical School,
Boston, MA) provided the expression vector with RSV-human Bcl-2 (Seto
et al., 1988). The histone 2B–GFP construct is from Dr. Jennifer Lippincott-
Schwartz (National Institutes of Health, Bethesda, MD).
The point mutants of RacV12 in the residues 26 and 130 were prepared
using the QuickChange site Mutagenesis Kit (Stratagene). RacV12 in
pcDNA3 was used as a template with the oligo 5 -CTGATCAGTTACA-
CAACCCATGCATTTCCTGGAG-3  to generate the H26 mutant and the
oligo 5 -CGAGAAACTGAACGAGAAGAAGCTGACTCC-3  to generate
the N130 change. The mutations were verified by sequencing.
Cells were transfected using adenovirus as described previously (Forsay-
eth and Garcia, 1994) (Kheradmand et al., 1998). Briefly, the cells were Integrins activate mitochondrial signaling | Werner and Werb 367
subcultured the day before. 3   10
6 cells were transfected in a 3.5-cm dish
with 2.5 ml of the following mixture: adenovirus stock diluted 1:20 in se-
rum and antibiotic-free DME, 2  g/ml of plasmid, and 80  g/ml DEAE-
dextran. The cells and the mixture were incubated for 2 h at 37 C and then
washed for 1 min with 10% DMSO in PBS and incubated overnight with
DME 10% FBS. The medium was then changed to DME-0.1% LH and 24 h
later. Equal numbers of cells were plated on fibronectin-coated dishes. The
cells were analyzed after 24 h by measuring luciferase activity in whole
cell lysates using a commercial kit (Promega). The readings were corrected
by protein concentration (Bradford) or  -galactosidase activity (Tropix).
Data analysis
The experimental data are represented as means   SEM. Statistical com-
parisons were performed using the two-tailed Student’s t test. Values of
P   0.05 were considered to be statistically significant.
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